Hideaki Bando Selected Research

Hideaki Bando Research Topics

Disease

61	Neoplasms (Cancer) 04/2024 - 06/2009
49	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 06/2009
23	Stomach Neoplasms (Stomach Cancer) 10/2023 - 06/2015
8	Neoplasm Metastasis (Metastasis) 03/2024 - 06/2009
6	Neutropenia 12/2021 - 01/2016
5	Disease Progression 04/2024 - 01/2020
5	Adenocarcinoma 10/2023 - 01/2018
5	Esophageal Squamous Cell Carcinoma 01/2023 - 07/2016
4	Rectal Neoplasms (Rectal Cancer) 03/2024 - 08/2020
4	Microsatellite Instability 01/2024 - 11/2018
4	Febrile Neutropenia 12/2021 - 07/2016
4	Esophageal Neoplasms (Esophageal Cancer) 02/2021 - 10/2019
3	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2023 - 12/2020
3	Ascites 01/2021 - 06/2009
3	Diarrhea 11/2020 - 04/2019
2	Carcinoma (Carcinomatosis) 01/2024 - 07/2016
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2023 - 09/2012
2	Vomiting 04/2019 - 05/2016
2	Hemorrhage 01/2018 - 12/2012
2	Lung Neoplasms (Lung Cancer) 01/2018 - 02/2012
2	Hyperglycemia 05/2016 - 08/2015
1	Breast Neoplasms (Breast Cancer) 04/2024
1	Residual Neoplasm 01/2024
1	Dermatitis 01/2024
1	Burns 01/2024
1	Hyperphosphatemia 02/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023
1	Pathologic Complete Response 01/2022

Drug/Important Bio-Agent (IBA)

15	Biomarkers (Surrogate Marker)IBA 03/2024 - 04/2015
13	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2023 - 12/2012
11	Circulating Tumor DNAIBA 04/2024 - 01/2018
11	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 01/2011
10	Irinotecan (Camptosar)FDA LinkGeneric 06/2023 - 06/2009
9	NivolumabIBA 02/2024 - 01/2019
9	Fluorouracil (Carac)FDA LinkGeneric 03/2023 - 09/2012
8	Cetuximab (Erbitux)FDA Link 03/2024 - 06/2009
8	ErbB Receptors (EGF Receptor)IBA 01/2024 - 01/2011
7	Bevacizumab (Avastin)FDA Link 03/2023 - 12/2012
7	AntibodiesIBA 01/2022 - 01/2011
6	Immune Checkpoint InhibitorsIBA 02/2024 - 11/2020
6	Monoclonal AntibodiesIBA 01/2024 - 11/2017
6	Cisplatin (Platino)FDA LinkGeneric 02/2021 - 01/2016
5	RamucirumabIBA 07/2022 - 01/2018
4	Leucovorin (Folinic Acid)FDA Link 03/2023 - 12/2012
4	trifluridine tipiracil drug combinationIBA 12/2019 - 01/2016
4	S-1 plus cisplatinIBA 01/2019 - 01/2016
3	Cell-Free Nucleic AcidsIBA 03/2024 - 07/2017
3	binimetinibIBA 03/2024 - 01/2020
3	encorafenibIBA 03/2024 - 01/2020
3	regorafenibIBA 02/2024 - 12/2016
3	Phosphotransferases (Kinase)IBA 05/2023 - 07/2017
3	pembrolizumabIBA 01/2022 - 01/2019
3	ParaffinIBA 01/2022 - 01/2011
3	Formaldehyde (Formol)FDA Link 01/2022 - 01/2011
3	Capecitabine (Xeloda)FDA Link 12/2021 - 03/2017
3	Codon (Codons)IBA 09/2013 - 11/2012
2	Epidermal Growth Factor (EGF)IBA 04/2024 - 12/2012
2	RNA (Ribonucleic Acid)IBA 02/2024 - 01/2022
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 05/2023 - 01/2018
2	Trastuzumab (Herceptin)FDA Link 01/2023 - 01/2022
2	LigandsIBA 01/2022 - 01/2022
2	napabucasinIBA 11/2021 - 01/2020
2	Docetaxel (Taxotere)FDA Link 02/2021 - 07/2016
2	SteroidsIBA 11/2020 - 05/2016
2	CreatinineIBA 04/2019 - 07/2016
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 01/2018
2	Insulin (Novolin)FDA Link 05/2016 - 08/2015
1	Hormones (Hormone)IBA 04/2024
1	abemaciclibIBA 04/2024
1	Indicators and Reagents (Reagents)IBA 03/2024
1	Trinitrotoluene (TNT)IBA 03/2024
1	TAS-116IBA 02/2024
1	Angiogenesis InhibitorsIBA 01/2024
1	trastuzumab deruxtecanIBA 01/2024
1	shiunkoIBA 01/2024
1	Taxoids (Taxanes)IBA 06/2023
1	Mitogen-Activated Protein KinasesIBA 05/2023
1	futibatinibIBA 02/2023
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 02/2023
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 02/2023
1	PlatinumIBA 01/2023
1	pertuzumabIBA 01/2023
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2022
1	ProteomeIBA 12/2022
1	niraparibIBA 12/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2022
1	lenvatinibIBA 01/2022
1	Hematoxylin (Haematoxylon)IBA 01/2022

Therapy/Procedure

39	Therapeutics 04/2024 - 09/2012
27	Drug Therapy (Chemotherapy) 03/2024 - 06/2009
10	Chemoradiotherapy 03/2024 - 09/2012
8	Precision Medicine 03/2024 - 02/2016
4	Immunotherapy 02/2024 - 04/2020
4	Adjuvant Chemotherapy 01/2023 - 03/2017
2	Genomic Medicine 11/2022 - 09/2018
2	Induction Chemotherapy 02/2021 - 07/2016
2	Gastrectomy 02/2019 - 03/2017
1	Neoadjuvant Therapy 03/2024
1	Radiotherapy 03/2024
1	Proctectomy 01/2023